Browse Negotiations Image Banner

Banner Text Velit velaliquam, ultricies eros dolore magna in in doming ullamco sint. Sint doming dignissim in quis pariatur consequat urna eu providerent. Sint dolore ea urna velit doming ea pulvinar.

General Callout

Nunc dolor esse suscipit eros eros ullamco dolor. Duis velaliquam sunt urna, tempuribud doming quis, laboris ultricies ultricies urna laboris. Nostrud pulvinar nostrud elit sunt ex exercitation magna tempuribud laboris ea ex nunc sed exercitation ea laboris dignissim.

Accordion

Quis harmud ea commodo voluptate dolor urna providerent tempor amet dignissim velit consectetur harmud sint doming, urna magna velit sed commodo urna sint sunt nunc. Nunc consectetur laboris harmud dolore exercitation sed magna laboris nulla velit velaliquam ultricies. Dignissim adipiscing, sed duis ultricies sint voluptate providerent nunc nisi.

Heading 1

Pariatur aliquip quis doming sint eros sit nulla consectetur velit quis consectetur ea dolore quis, eros voluptate commodo quis doming sint aliquip esse tempuribud quis velit ut ut aliquip ex quis, ullamco eu in. Nisi nulla amet quis tempor tempuribud aliquip. Adipiscing nostrud eu fugiat, duis quis sunt eu, providerent sed quis pariatur velit amet dolore in.

Heading 2

Pariatur aliquip quis doming sint eros sit nulla consectetur velit quis consectetur ea dolore quis, eros voluptate commodo quis doming sint aliquip esse tempuribud quis velit ut ut aliquip ex quis, ullamco eu in. Nisi nulla amet quis tempor tempuribud aliquip. Adipiscing nostrud eu fugiat, duis quis sunt eu, providerent sed quis pariatur velit amet dolore in.

Related content

Dolor commodo suscipit adipiscing suscipit, elit dolore velit. Amet tempuribud velit pariatur ullamco exercitation esse dolore sint velaliquam adipiscing eu pulvinar doming sunt, dignissim velit voluptate ex suscipit sunt ex, duis dignissim nunc tempuribud laboris commodo velit ut. Velit in harmud quis voluptate esse nulla.

Shop Now!

Laboris quis consectetur sed eros velit tempuribud suscipit magna ea consequat laboris. Elit adipiscing quis sunt duis magna nulla velit amet elit ex providerent consectetur tempuribud amet ex commodo urna, magna adipiscing elit sed duis nisi pulvinar, doming pariatur velaliquam quis providerent fugiat ea aliquip sit ut nisi sunt pulvinar eu velit.

grey rec centre

Call to action

Esse suscipit in eros ea sed voluptate dolore, harmud nisi, dolore ultricies fugiat amet doming ut sint ut adipiscing. Sit velit velaliquam ex nunc ut voluptate

Primary Button Secondary Button

Search by drug, manufacturer, or indication

Displaying 1071 - 1080 of 1165

Gazyva (obinutuzumab)

Status:

Concluded with an LOI

Manufacturer:

Hoffmann-La Roche Ltd.

Indication:

Chronic Lymphocytic Leukemia: As monotherapy for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.

Last updated May 15, 2015

Diacomit (stiripentol)

Status:

Concluded with an LOI

Manufacturer:

Biocodex SA

Indication:

Dravet Syndrome (DS)

Last updated May 11, 2015

Anoro Ellipta (umeclidinium/vilanterol)

Status:

Concluded with an LOI

Manufacturer:

GlaxoSmithKline Inc.

Indication:

Chronic Obstructive Pulmonary Disease (COPD)

Last updated May 1, 2015

Signifor (pasireotide diaspartate)

Status:

Negotiations were not pursued

Manufacturer:

Novartis Pharmaceuticals Canada Inc.

Indication:

Cushing's disease

Last updated April 30, 2015

Rebif (interferon beta-1a)

Status:

Concluded with an LOI

Manufacturer:

EMD Serono Canada, a division of EMD Inc.

Indication:

Clinically Isolated Syndrome

Last updated April 21, 2015

Ultibro Breezhaler (indacaterol/glycopyrronium)

Status:

Concluded with an LOI

Manufacturer:

Novartis Pharmaceuticals Canada Inc.

Indication:

Chronic Obstructive Pulmonary Disease (COPD)

Last updated April 20, 2015

Myrbetriq (mirabegron)

Status:

Concluded with an LOI

Manufacturer:

Astellas Pharma Inc.

Indication:

Overactive Bladder

Last updated April 8, 2015

Tivicay (dolutegravir)

Status:

Concluded with an LOI

Manufacturer:

ViiV Healthcare

Indication:

HIV-1 Infection

Last updated April 8, 2015

Triumeq (dolutegravir/abacavir/lamivudine)

Status:

Concluded with an LOI

Manufacturer:

ViiV Healthcare

Indication:

HIV-1 Infection

Last updated April 8, 2015

Inspra (eplerenone)

Status:

Concluded with an LOI

Manufacturer:

Pfizer Canada ULC

Indication:

Post myocardial infarction

Last updated March 31, 2015